Revive Therapeutics Ltd (RVV.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 1 | 1 | 2 | 2 | 2 |
| Accounts receivable | 13 | -18 | 32 | 17 | -2 |
| Other Working Capital | -175 | -287 | 204 | 219 | -2 |
| Other Operating Activity | -278 | -334 | -501 | -491 | -766 |
| Operating Cash Flow | $-439 | $-638 | $-264 | $-254 | $-769 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | -2 | 0 | 0 | 0 |
| Investing Cash Flow | $0 | $-2 | $0 | $0 | $0 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 0 | 1,500 | 845 | N/A | N/A |
| Other Financing Activity | 45 | -93 | -15 | 0 | 0 |
| Financing Cash Flow | $45 | $1,407 | $829 | $N/A | $N/A |
| Beginning Cash Position | 2,100 | 1,333 | 768 | 1,022 | 1,790 |
| End Cash Position | 1,706 | 2,100 | 1,333 | 768 | 1,022 |
| Net Cash Flow | $-394 | $767 | $565 | $-254 | $-769 |
| Free Cash Flow | |||||
| Operating Cash Flow | -439 | -638 | -264 | -254 | -769 |
| Capital Expenditure | N/A | -2 | N/A | N/A | N/A |
| Free Cash Flow | -439 | -640 | -264 | -254 | -769 |